oxybutynin has been researched along with naloxone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Algate, DR; Beard, DJ | 1 |
| Doi, T; Fujimura, M; Hashimoto, T; Hirakata, M; Iwata, M; Izumimoto, N; Kanie, S; Kawai, K; Kobayashi, R; Komagata, T; Momen, S; Okanishi, S; Yoshikawa, S; Yoshimura, N | 1 |
| Jones, BE; Nelson, L; Prosser, JM | 1 |
| Ito, M; Kanamura, K; Kato, Y; Kinoshita, M; Kominami, K; Mafune, S; Sutoh, C; Takasuga, S; Yamamoto, R; Yamauchi, M; Yoshida, Y | 1 |
| Doris, MK; Sandilands, EA | 1 |
| Grzonkowski, P; Kacprzak, Ł; Kuczyńska, K; Zawilska, JB | 1 |
| Grasso, SC; Hess, JA; Ko, JC; Paranjape, V; Payton, M; Weil, AB | 1 |
| Hessulf, F | 1 |
| Harrison, S; Kay, S; Lam, D; Pickard, J | 1 |
| Coenen, J; Friebe, M | 1 |
2 review(s) available for oxybutynin and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Abuse of fentanyl: An emerging problem to face.
Topics: Analgesics, Opioid; Dosage Forms; Drug Contamination; Drug Overdose; Drug Trafficking; Fentanyl; Humans; Illicit Drugs; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Transdermal Patch | 2018 |
12 other study(ies) available for oxybutynin and naloxone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The physical dependence liabilities of oxybutynin and morphine in rats.
Topics: Animals; Male; Mandelic Acids; Morphine; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1985 |
Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.
Topics: Afferent Pathways; Analgesics, Opioid; Animals; Electric Stimulation; Guinea Pigs; Male; Mandelic Acids; Morphinans; Morphine; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naloxone; Narcotic Antagonists; Peripheral Nerves; Phthalimides; Rats; Rats, Wistar; Receptors, Opioid, mu; Reflex; Spinal Cord Injuries; Urinary Bladder; Urination; Urodynamics | 2017 |
Complications of oral exposure to fentanyl transdermal delivery system patches.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Databases, Factual; Female; Fentanyl; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Poisoning; Respiration, Artificial; Substance-Related Disorders; Suicide, Attempted; Transdermal Patch; Treatment Outcome | 2010 |
In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
Topics: Administration, Cutaneous; Animals; Electrodes; Equipment Design; Feasibility Studies; Iontophoresis; Male; Models, Biological; Naloxone; Narcotic Antagonists; Permeability; Rats; Rats, Sprague-Dawley; Silver Compounds; Skin; Skin Absorption; Swine; Transdermal Patch | 2012 |
Life-threatening opioid toxicity from a fentanyl patch applied to eczematous skin.
Topics: Administration, Cutaneous; Analgesics, Opioid; Eczema; Fentanyl; Humans; Male; Naloxone; Narcotic Antagonists; Self Medication; Transdermal Patch; Young Adult | 2015 |
Effects of transdermal fentanyl solution application and subsequent naloxone hydrochloride administration on minimum alveolar concentration of isoflurane in dogs.
Topics: Analgesics, Opioid; Animals; Dogs; Female; Fentanyl; Isoflurane; Male; Naloxone; Narcotic Antagonists; Pulmonary Alveoli; Reference Values; Transdermal Patch | 2018 |
Can't take the heat: sauna and Fentanyl patch intoxication.
Topics: Aged, 80 and over; Analgesics, Opioid; Emergency Medical Services; Fentanyl; Hot Temperature; Humans; Male; Naloxone; Narcotic Antagonists; Steam Bath; Transdermal Patch | 2019 |
Unusual case of transdermal fentanyl in cachexia.
Topics: Analgesics, Opioid; Cachexia; Female; Fentanyl; Hospices; Humans; Middle Aged; Naloxone; Narcotic Antagonists; Pain; Pressure Ulcer; Skin Absorption; Transdermal Patch | 2019 |
[Overdose from a patch].
Topics: Aged, 80 and over; Analgesics, Opioid; Consciousness Disorders; Drug Overdose; Female; Fentanyl; Humans; Naloxone; Narcotic Antagonists; Transdermal Patch | 2021 |